Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities researchers at Leerink Partnrs upped their FY2024 EPS estimates for shares of Amylyx Pharmaceuticals in a note issued to investors on Monday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per share of $1.45 for the year, up from […]
Amylyx Stock: Balancing Growth And Market Challenges (Rating Downgrade) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.